MoonLake Immunotherapeutics (NASDAQ:MLTX) IPO

MoonLake Immunotherapeutics

IPO

Went public as Helix Acquisition Corp, a blank check company (SPAC). Priced at US$10.00 a share on Oct 19, 2020.

Price
US$10.00 a share
Shares offered
10,000,000 Class A ordinary shares
Offering size
US$100 million
Underwriters' option
Up to 1,500,000 more shares
Listing
HLXA on the Nasdaq Capital Market
Underwriter
Jefferies
Shares delivered
On or about Oct 22, 2020

Steps

StepWhen
Draft sent to the SEC in confidenceAug 28, 2020
Filed publiclyOct 1, 2020
Amended twiceNewest Oct 16, 2020
Shares registered with an exchangeOct 19, 2020
Declared effective by the SECOct 19, 2020
Final prospectus, with the priceOct 21, 2020

From the cover of the final prospectus (424B4) filed Oct 21, 2020